Patents by Inventor Takeo Yoshioka

Takeo Yoshioka has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11955596
    Abstract: A solid electrolyte that includes a lithium ion conductive material having a garnet-type structure, a lithium ion conductive material having a LISICON-type structure, and a compound containing Li and B.
    Type: Grant
    Filed: December 4, 2019
    Date of Patent: April 9, 2024
    Assignee: MURATA MANUFACTURING CO., LTD.
    Inventors: Ryohei Takano, Makoto Yoshioka, Akisuke Ito, Takeo Ishikura
  • Patent number: 11942596
    Abstract: A solid electrolyte material that includes a composite oxide containing Li and Bi, and at least one solid electrolyte having a garnet structure, a perovskite structure, and a LISICON structure.
    Type: Grant
    Filed: December 4, 2019
    Date of Patent: March 26, 2024
    Assignee: MURATA MANUFACTURING CO., LTD.
    Inventors: Ryohei Takano, Makoto Yoshioka, Takeo Ishikura, Akisuke Ito
  • Patent number: 7555953
    Abstract: There is provided a condition detection apparatus for detecting a present operating condition of a linear rolling motion guide apparatus, and the condition detection apparatus includes an AE sensor 1 for detecting a waveform elastically generated at least due to rolling of balls included in the linear rolling motion guide apparatus and mutual collision of the balls and generating an electric detection signal corresponding the detected waveform, a waveform shaping unit 2, an A/D converter 3, and a signal processing unit 4 judging a content of the operation condition in response to the generated detected signal Sae.
    Type: Grant
    Filed: February 27, 2004
    Date of Patent: July 7, 2009
    Assignee: THK Co., Ltd.
    Inventors: Takeo Yoshioka, Yoshiyuki Honjyo, Shigeo Watanabe
  • Patent number: 7546211
    Abstract: A condition detection apparatus comprising an AE sensor 1 that detects AE waves, which elastically-occur when a plurality of balls included in an LM system self-rotate and revolve within a circulation section at the same time, and generates detection signals Sae, and a signal processing unit 4 that generates a first parameter indicating an intensity of the AE waves based on the generated detection signals Sae, generates based on the detection signals Sae a second parameter by weighting only detection signals Sae temporally-continuously detected among the detection signals Sae, generates based on the detection signals Sae a third parameter by weighting only detection signals Sae temporally-discontinuously detected in correspondence with the movement of the balls among the detection signals Sae, and judges contents of an operational condition of the LM system using any one of the first, second or third parameter, is provided to enable prognosis of occurrences of failures in the LM system, to improve maintainabi
    Type: Grant
    Filed: August 30, 2005
    Date of Patent: June 9, 2009
    Assignee: THK Co., Ltd.
    Inventors: Takeo Yoshioka, Yoshiyuki Honjo, Shigeo Watanabe
  • Publication number: 20080065354
    Abstract: A condition detection apparatus comprising an AE sensor 1 that detects AE waves, which elastically-occur when a plurality of balls included in an LM system self-rotate and revolve within a circulation section at the same time, and generates detection signals Sae, and a signal processing unit 4 that generates a first parameter indicating an intensity of the AE waves based on the generated detection signals Sae, generates based on the detection signals Sae a second parameter by weighting only detection signals Sae temporally-continuously detected among the detection signals Sae, generates based on the detection signals Sae a third parameter by weighting only detection signals Sae temporally-discontinuously detected in correspondence with the movement of the balls among the detection signals Sae, and judges contents of an operational condition of the LM system using any one of the first, second or third parameter, is provided to enable prognosis of occurrences of failures in the LM system, to improve maintainabi
    Type: Application
    Filed: August 30, 2005
    Publication date: March 13, 2008
    Applicant: THK CO., LTD.
    Inventors: Takeo Yoshioka, Yoshiyuki Honjo, Shigeo Watanabe
  • Patent number: 7235388
    Abstract: Provided are an isolated gene capable of participating in the production of L-homoglutamic acid, and a production system of L-homoglutamic acid by using this gene. The gene is derived from the genome of Flavobacterium lutescens.
    Type: Grant
    Filed: June 3, 2004
    Date of Patent: June 26, 2007
    Assignee: Mercian Corporation
    Inventors: Tadashi Fujii, Takao Narita, Kuniho Nakata, Hitosi Agematu, Hiroshi Tsunekawa, Kunio Isshiki, Takeo Yoshioka
  • Publication number: 20060213272
    Abstract: There is provided a condition detection apparatus for detecting a present operating condition of a linear rolling motion guide apparatus, and the condition detection apparatus includes an AE sensor 1 for detecting a waveform elastically generated at least due to rolling of balls included in the linear rolling motion guide apparatus and mutual collision of the balls and generating an electric detection signal corresponding the detected waveform, a waveform shaping unit 2, an A/D converter 3, and a signal processing unit 4 judging a content of the operation condition in response to the generated detected signal Sae.
    Type: Application
    Filed: February 27, 2004
    Publication date: September 28, 2006
    Applicant: THK CO., LTD.
    Inventors: Takeo Yoshioka, Yoshiyuki Honjyo, Shigeo Watanabe
  • Patent number: 6890746
    Abstract: Provided are an isolated gene capable of participating in the production of L-homoglutamic acid, and a production system of L-homoglutamic acid by using this gene. The gene is derived from the genome of Flavobacterium lutescens.
    Type: Grant
    Filed: August 4, 1999
    Date of Patent: May 10, 2005
    Assignee: Mercian Corporation
    Inventors: Tadashi Fujii, Takao Narita, Kuniho Nakata, Hitosi Agematu, Hiroshi Tsunekawa, Kunio Isshiki, Takeo Yoshioka
  • Publication number: 20040214295
    Abstract: Provided are an isolated gene capable of participating in the production of L-homoglutamic acid, and a production system of L-homoglutamic acid by using this gene. The gene is derived from the genome of Flavobacterium lutescens.
    Type: Application
    Filed: June 3, 2004
    Publication date: October 28, 2004
    Inventors: Tadashi Fujii, Takao Narita, Kuniho Nakata, Hitosi Agematu, Hiroshi Tsunekawa, Kunio Isshiki, Takeo Yoshioka
  • Patent number: 6747012
    Abstract: Disclosed are a crystalline form of anthracycline antibiotic having specific characteristic 2&thgr; values as measured by the X-ray diffraction method, and a process for producing the crystalline form. This process comprises the step of crystallization involving the combined use of a specific poor solvent for the antibiotic and a good solvent thereof. This crystalline form has excellent chemical and physical properties.
    Type: Grant
    Filed: June 1, 2000
    Date of Patent: June 8, 2004
    Assignee: Mercian Corporation
    Inventors: Osamu Johdo, Kiyotomo Nakamura, Takeo Yoshioka
  • Publication number: 20040024015
    Abstract: A method for enhancing the efficacy of chemotherapy and/or radiation in the treatment of cancer in animals, particularly humans, is provided wherein certain isocoumarin derivatives which exhibit unique radiosensitization activity and/or chemopotentiation properties are employed in a combination treatment with ionizing radiation and/or chemotherapy.
    Type: Application
    Filed: June 30, 2003
    Publication date: February 5, 2004
    Inventors: Corinne L. Reimer, Naoki Agata, Tomio Takeuchi, Hiroyuki Kumagai, Takeo Yoshioka, Masaaki Ishizuka, Donald W. Kufe, Ralph R. Weichselbaum
  • Patent number: 6653455
    Abstract: Disclosed are a crystallizing method of doxorubicin hydrochloride from a doxorubicin hydrochloride-containing solution, particularly a method for carrying out the crystallization under a condition of 40° C. or higher, and a doxorubicin hydrochloride crystalline aggregate having particularly an excellent solubility in water.
    Type: Grant
    Filed: April 13, 2001
    Date of Patent: November 25, 2003
    Assignee: Mercian Corporation
    Inventors: Osamu Johdo, Takuma Nakao, Takeo Yoshioka
  • Patent number: 6589981
    Abstract: A method for enhancing the efficacy of chemotherapy and/or radiation in the treatment of cancer in animals, particularly humans, is provided wherein certain isocoumarin derivatives which exhibit unique radiosensitization activity and/or chemopotentiation properties are employed in a combination treatment with ionizing radiation and/or chemotherapy.
    Type: Grant
    Filed: February 27, 2001
    Date of Patent: July 8, 2003
    Assignees: ILEX Oncology, Inc., Mercian Corporation
    Inventors: Corinne L. Reimer, Naoki Agata, Tomio Takeuchi, Hiroyuki Kumagai, Takeo Yoshioka, Masaaki Ishizuka, Donald W. Kufe, Ralph R. Weichselbaum
  • Patent number: 6566394
    Abstract: Salicylamide derivatives represented by formulae (1a) and (1b); intermediates in the production thereof; a process for producing the same; and drugs containing the same as the active ingredient. The salicylamide derivatives represented by formulae (1a) and (1b) are useful as anti-inflammatory agents and immunosuppressive agents which exert an effect of inhibiting the activation of NF-&kgr;B with little side effects.
    Type: Grant
    Filed: May 30, 2002
    Date of Patent: May 20, 2003
    Assignees: Mercian Corporation, Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai
    Inventors: Tomio Takeuchi, Kazuo Umezawa, Sakino To-E, Naoki Matsumoto, Tsutomu Sawa, Takeo Yoshioka, Naoki Agata, Shin-ichi Hirano, Kunio Isshiki
  • Patent number: 6410759
    Abstract: A method for preparing at least one hydroxycholesterol chosen from the group consisting of 25-hydroxycholesterol, 17,25-dihydroxycholesterol and 25,26-dihydroxycholesterol by biological hydroxylation of cholesterol, and the aforementioned dihydroxycholesterols. In the above biological hydroxylation, a microorganism is used which has the abovementioned hydroxylation capacity and which belongs to the genus Amycolata and the genus Sphingomonas.
    Type: Grant
    Filed: July 31, 2000
    Date of Patent: June 25, 2002
    Assignee: Mercian Corporation
    Inventors: Koji Takeda, Tadashi Terasawa, Kazuyuki Dobashi, Takeo Yoshioka
  • Patent number: 6388058
    Abstract: The present invention relates to a method in which daunomycin is eluted from a hydrophobic porous synthetic resin carrier onto which daunomycin is adsorbed from crude daunomycin with a buffered aqueous solution containing a water-miscible organic solvent to recover purified daunomycin. Daunomycin (daunorubicin) is purified efficiently.
    Type: Grant
    Filed: February 25, 2000
    Date of Patent: May 14, 2002
    Assignee: Mercian Corporation
    Inventors: Osamu Johdo, Konomi Iguchi, Takeo Yoshioka
  • Patent number: 6361987
    Abstract: This invention provides DNA fragments for efficiently preparing a protein having asymmetric hydrolase activity for 4-substituted 1,4-dihydropyridine derivatives, transformants obtained by using such a DNA fragment, and a process for preparing the aforesaid enzyme. Specifically, an isolated gene derived from the chromosome of Streptomyces viridosporus and encoding a protein having asymmetric hydrolase activity for 4-substituted 1,4-dihydropyridine derivatives, plasmids having the aforesaid gene integrated thereinto, transformants obtained by using such a plasmid, and a process for preparing the aforesaid enzyme by using such a transformant are disclosed. A process for the enzymatic conversion of 4-substituted 1,4-dihydropyridine derivatives by using the aforesaid enzyme is also disclosed.
    Type: Grant
    Filed: February 28, 2000
    Date of Patent: March 26, 2002
    Assignee: Mercian Corporation
    Inventors: Akira Arisawa, Motoko Matsufuji, Takurou Tsuruta, Kazuyuki Dobashi, Takashi Nakashima, Kunio Isshiki, Takeo Yoshioka
  • Publication number: 20020019366
    Abstract: A method for enhancing the efficacy of chemotherapy and/or radiation in the treatment of cancer in animals, particularly humans, is provided wherein certain isocoumarin derivatives which exhibit unique radiosensitization activity and/or chemopotentiation properties are employed in a combination treatment with ionizing radiation and/or chemotherapy.
    Type: Application
    Filed: February 27, 2001
    Publication date: February 14, 2002
    Inventors: Corinne L. Reimer, Naoki Agata, Tomio Takeuchi, Hiroyuki Kumagai, Takeo Yoshioka, Masaaki Ishizuka, Donald W. Kufe, Ralph R. Weichselbaum
  • Patent number: 6146844
    Abstract: A method for preparing at least one hydroxycholesterol chosen from the group consisting of 25-hydroxycholesterol, 17,25-dihydroxycholesterol and 25,26-dihydroxycholesterol by biological hydroxylation of cholesterol, and the aforementioned dihydroxycholesterols. In the above biological hydroxylation, a microorganism is used which has the abovementioned hydroxylation capacity and which belongs to the genus Amycolata and the genus Sphingomonas.
    Type: Grant
    Filed: February 26, 1998
    Date of Patent: November 14, 2000
    Assignee: Mercian Corporation
    Inventors: Koji Takeda, Tadashi Terasawa, Kazuyuki Dobashi, Takeo Yoshioka
  • Patent number: 6143541
    Abstract: This invention provides DNA fragments for efficiently preparing a protein having asymmetric hydrolase activity for 4-substituted 1,4-dihydropyridine derivatives, transformants obtained by using such a DNA fragment, and a process for preparing the aforesaid enzyme. Specifically, an isolated gene derived from the chromosome of Streptomyces viridosporus and encoding a protein having asymmetric hydrolase activity for 4-substituted 1,4-dihydropyridine derivatives, plasmids having the aforesaid gene integrated thereinto, transformants obtained by using such a plasmid, and a process for preparing the aforesaid enzyme by using such a transformant are disclosed. A process for the enzymatic conversion of 4-substituted 1,4-dihydropyridine derivatives by using the aforesaid enzyme is also disclosed.
    Type: Grant
    Filed: January 30, 1998
    Date of Patent: November 7, 2000
    Assignee: Mercian Corporation
    Inventors: Akira Arisawa, Motoko Matsufuji, Takurou Tsuruta, Kazuyuki Dobashi, Takashi Nakashima, Kunio Isshiki, Takeo Yoshioka